Inventor · disambiguated record
Wolfgang Glaesner
Also filed as: GLAESNER WOLFGANG
13 granted patents·11 pending applications·914 citations·filing 2001–2013
94Inventor score
Top patents by PatentIndex Score
24 records- 0197US7101843B2Glucagon-like peptide-1 analogsLILLY CO ELI·Filed 2002·Granted Sep 5, 2006·149 cites·5 claims
- 0296US7576190B2FGF-21 fusion proteinsLILLY CO ELI·Filed 2005·Granted Aug 18, 2009·75 cites·3 claims
- 0396US7271149B2GLP-1 fusion proteinsLILLY CO ELI·Filed 2001·Granted Sep 18, 2007·232 cites·13 claims
- 0496US7084243B2Glucagon-like peptide-1 analogsLILLY CO ELI·Filed 2001·Granted Aug 1, 2006·134 cites·14 claims
- 0595US7199217B2Amidated glucagon-like peptide-1LILLY CO ELI·Filed 2001·Granted Apr 3, 2007·65 cites·1 claims
- 0694US7491697B2Muteins of fibroblast growth factor 21LILLY CO ELI·Filed 2004·Granted Feb 17, 2009·106 cites·9 claims
- 0792US7452966B2GLP-1 analog fusion proteinsLILLY CO ELI·Filed 2004·Granted Nov 18, 2008·56 cites·5 claims
- 0891US8557769B2Co-administration of FGF-21 and GLP-1 to treat diabetes and lower blood glucoseCOSKUN TAMER·Filed 2012·Granted Oct 15, 2013·28 cites·2 claims
- 0988US7557183B2Polyethylene glycol linked GLP-1 compoundsLILLY CO ELI·Filed 2004·Granted Jul 7, 2009·36 cites·10 claims
- 1084US8273854B2GLP-1 analog fusion proteinsGLAESNER WOLFGANG·Filed 2008·Granted Sep 25, 2012·10 cites·6 claims
- 1183US7498308B2Method of treating a subject suffering stroke comprising administering Glucagon-like peptide-1 analogsLILLY CO ELI·Filed 2006·Granted Mar 3, 2009·6 cites·2 claims
- 1281US8183340B2GLP-1 pegylated compoundsGLAESNER WOLFGANG·Filed 2006·Granted May 22, 2012·7 cites·4 claims
- 1376US7482321B2Extended glucagon-like peptide-1 analogsLILLY CO ELI·Filed 2003·Granted Jan 27, 2009·10 cites·16 claims
- 1461US2011034373A1Use of an fgf-21 compound and a glp-1 compound for the treatment of obesityLILLY CO ELI·Filed 2008·Application pending·0 cites
- 1556US2014024586A1Use of an fgf-21 compound and a glp-1 compound for the treatment of obesityLILLY CO ELI·Filed 2013·Application pending·0 cites
- 1654US2007100133A1Erythropoietic compoundsBEALS JOHN M·Filed 2006·Application pending·0 cites
- 1751US2009118190A1Muteins of fibroblast growth factor 21BEALS JOHN MICHAEL·Filed 2009·Application pending·0 cites
- 1845US2007253966A1Fusion ProteinsLILLY CO ELI·Filed 2004·Application pending·0 cites
- 1944US2007161087A1Glp-1 fusion proteinsGLAESNER WOLFGANG·Filed 2007·Application pending·0 cites
- 2043US2006252693A1Glucagon-like peptide-1 analogsGLAESNER WOLFGANG·Filed 2006·Application pending·0 cites
- 2143US2009232807A1Glp-1 analog fusion protein formulationsLILLY CO ELI·Filed 2005·Application pending·0 cites
- 2241US2008026996A1Selective Vpac2 Receptor Reptide AgonistsLILLY CO ELI·Filed 2005·Application pending·0 cites
- 2340US2008096811A1Selective vpac2 receptor peptide agonistsLILLY CO ELI·Filed 2005·Application pending·0 cites
- 2439US2007265200A1Glycol Linked Fgf-21 CompoundsLILLY CO ELI·Filed 2005·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Wolfgang Glaesner files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →